Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Adobe’s new Firefly AI Assistant wants to run Photoshop, Premiere, Illustrator and more from one prompt
Adobe today launched its most ambitious AI offensive to date, unveiling the Firefly AI Assistant — a new agentic creative tool that can orchestrate complex, multi-step workflows across the company&# [...]
Adobe Foundry wants to rebuild Firefly for your brand — not just tweak it
Hoping to attract more enterprise teams to its ecosystem, Adobe launched a new model customization service called Adobe AI Foundry, which would create bespoke versions of its flagship AI model, Firefl [...]
Adobe's Firefly can now use AI to generate soundtracks, speech and video
Adobe has released the latest version of Firefly that now leans heavily on AI for nearly every facet of video and image post-production. The updated app can now use AI to generate narration, music, im [...]
FDA approves at-home pap smear alternative device for cervical cancer screening
The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]
Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck
For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science a [...]
Adobe Firefly can now generate sound effects from your audio cues
Since rolling out the redesign of its Firefly app in April, Adobe has been releasing major updates for the generative AI hub at a near monthly clip. Today, the company is introducing a handful of new [...]
Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years
Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the r [...]